Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
High-Throughput Assay Tracks Range of SARS-CoV-2 Vaccination Responses
03/22/2023
Jolynn Tumolo
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an...
03/22/2023
First Report Managed Care
News
ALS Therapy Receives FDA Orphan Drug Designation
03/21/2023
Jolynn Tumolo
The US Food and Drug Administration (FDA) recently granted Orphan Drug Designation to RAG-17, a novel short interfering RNA (siRNA) modality for the treatment of patients with amyotrophic lateral sclerosis (ALS), biopharmaceutical company...
The US Food and Drug Administration (FDA) recently granted Orphan Drug Designation to RAG-17, a novel short interfering RNA (siRNA) modality for the treatment of patients with amyotrophic lateral sclerosis (ALS), biopharmaceutical company...
The US Food and Drug...
03/21/2023
Neurology
News
Meta-Analysis Detects 27 Genetic Variants That Increase ADHD Risk
03/20/2023
Jolynn Tumolo
A genome-wide association study meta-analysis has identified 27 loci in the human genome, more than double the amount detected in previous studies, that increase the risk of attention-deficit/hyperactivity disorder (ADHD). An international...
A genome-wide association study meta-analysis has identified 27 loci in the human genome, more than double the amount detected in previous studies, that increase the risk of attention-deficit/hyperactivity disorder (ADHD). An international...
A genome-wide association study...
03/20/2023
Psych Congress Network
News
Reduced Bone Mineral Density Persists Long-term for Patients With Hemophilia
03/20/2023
Jolynn Tumolo
In addition to identifying factors that contribute to osteoporosis in people with hemophilia, researchers recommended standardized screening of patients' vitamin D levels and joint health. 
In addition to identifying factors that contribute to osteoporosis in people with hemophilia, researchers recommended standardized screening of patients' vitamin D levels and joint health. 
In addition to identifying...
03/20/2023
First Report Managed Care
News
Study Suggests Increasing Global Burden of Multiple Sclerosis
03/17/2023
Jolynn Tumolo
"This study aimed to investigate the global, regional, and national burden and temporal trends in MS incidence, deaths, and disability-adjusted life years from 1990 to 2019," researchers said. 
"This study aimed to investigate the global, regional, and national burden and temporal trends in MS incidence, deaths, and disability-adjusted life years from 1990 to 2019," researchers said. 
"This study aimed to investigate...
03/17/2023
First Report Managed Care
News
Global Study Finds Higher Risk of Stroke in People With Depression
03/17/2023
Jolynn Tumolo
Depressive symptoms are associated with not only an increased risk of stroke but also worse functional outcomes afterward, according to results from a global study published in Neurology.
Depressive symptoms are associated with not only an increased risk of stroke but also worse functional outcomes afterward, according to results from a global study published in Neurology.
Depressive symptoms are...
03/17/2023
Neurology
News
Ophthalmic Solution Recalled
03/17/2023
Jolynn Tumolo
A recall has been issued for several lots of ophthalmic solution due to potentially cracked bottle cap lids.
A recall has been issued for several lots of ophthalmic solution due to potentially cracked bottle cap lids.
A recall has been issued for...
03/17/2023
Pharmacy Learning Network
News
Diabetes Drug Recalled
03/17/2023
Jolynn Tumolo
A Class II recall has been issued for more than 12,000 bottles of metformin hydrochloride meant to treat type 2 diabetes mellitus.
A Class II recall has been issued for more than 12,000 bottles of metformin hydrochloride meant to treat type 2 diabetes mellitus.
A Class II recall has been...
03/17/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Eye Drops
03/17/2023
Jolynn Tumolo
A Class I recall has been issued for eye drops used as an anti-inflammatory for symptoms of ocular irritation and swelling.
A Class I recall has been issued for eye drops used as an anti-inflammatory for symptoms of ocular irritation and swelling.
A Class I recall has been issued...
03/17/2023
Pharmacy Learning Network
News
IL-23 Inhibitors Outperform Placebo for Treatment of Psoriatic Arthritis, Meta-Analysis Shows
03/16/2023
Jolynn Tumolo
“IL-23 inhibitors have the potential to be a promising therapeutic option, especially for...patients who have an insufficient response to conventional synthetic disease-modifying antirheumatic drugs,” researchers wrote.
“IL-23 inhibitors have the potential to be a promising therapeutic option, especially for...patients who have an insufficient response to conventional synthetic disease-modifying antirheumatic drugs,” researchers wrote.
“IL-23 inhibitors have the...
03/16/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use